Mallinckrodt Pharmaceuticals CEO and key executive team

Mallinckrodt Pharmaceuticals's President, Chief Executive Officer & Director is Mark Trudeau. Mallinckrodt Pharmaceuticals's key executives include Mark Trudeau and 18 others.
Mark Trudeau

Mark Trudeau

President, Chief Executive Officer & Director
Spiro Gavaris

Spiro Gavaris

President, Specialty Generics
Angus Russell

Angus Russell

Chairman of the Board
Mark Casey

Mark Casey

Executive Vice President and Chief Legal Officer
Michele Robertson

Michele Robertson

Senior Vice President and Chief Compliance Officer
Brandi Robinson

Brandi Robinson

Senior Vice President and Chief Communications Officer
David Carlucci

David Carlucci

Director
Hugh O'Neill

Hugh O'Neill

Executive Vice President and Chief Commercial and Operations Officer
Bryan Reasons

Bryan Reasons

Executive Vice President and Chief Financial Officer
Kathleen Schaefer

Kathleen Schaefer

President, Mallinckrodt Enterprises LLC & Vice President and Corporate Controller
Paul R. Carter

Paul R. Carter

Director
Ian Watkins

Ian Watkins

Executive Vice President and Chief Human Resources Officer
Steven Romano

Steven Romano

Executive Vice President and Chief Scientific Officer
David Norton

David Norton

Director
Joann Reed

Joann Reed

Director
Carlos V. Paya

Carlos V. Paya

Director
Daniel Speciale

Daniel Speciale

Vice President, Finance and Investor Relations Officer
Anne C. Whitaker

Anne C. Whitaker

Director
Kneeland Youngblood

Kneeland Youngblood

Director
Last updated: